Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1937 1
1938 2
1939 1
1942 1
1945 1
1946 3
1947 7
1948 3
1949 13
1950 7
1951 5
1952 8
1953 11
1954 8
1955 9
1956 14
1957 14
1958 7
1959 12
1960 7
1961 9
1962 8
1963 12
1964 21
1965 8
1966 14
1967 11
1968 14
1969 16
1970 22
1971 13
1972 11
1973 11
1974 16
1975 28
1976 26
1977 30
1978 31
1979 36
1980 31
1981 36
1982 37
1983 47
1984 65
1985 38
1986 50
1987 47
1988 54
1989 69
1990 70
1991 45
1992 62
1993 72
1994 80
1995 92
1996 103
1997 96
1998 92
1999 89
2000 79
2001 89
2002 84
2003 106
2004 112
2005 95
2006 116
2007 114
2008 123
2009 144
2010 153
2011 156
2012 174
2013 194
2014 196
2015 223
2016 203
2017 212
2018 208
2019 187
2020 243
2021 284
2022 279
2023 247
2024 241
2025 66

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,598 results

Results by year

Filters applied: . Clear all
Page 1
Giant Cell Tumor of Bone: An Update.
Basu Mallick A, Chawla SP. Basu Mallick A, et al. Curr Oncol Rep. 2021 Mar 22;23(5):51. doi: 10.1007/s11912-021-01047-5. Curr Oncol Rep. 2021. PMID: 33754215 Review.
PURPOSE OF REVIEW: To highlight the new developments in the management of advanced giant cell tumor of bone, a rare locally aggressive benign tumor, which was traditionally managed with surgery alone by either curettage and local adjuvant …
PURPOSE OF REVIEW: To highlight the new developments in the management of advanced giant cell tumor of bone
Current management of giant-cell tumor of bone in the denosumab era.
Nagano A, Urakawa H, Tanaka K, Ozaki T. Nagano A, et al. Jpn J Clin Oncol. 2022 May 5;52(5):411-416. doi: 10.1093/jjco/hyac018. Jpn J Clin Oncol. 2022. PMID: 35199172 Review.
Giant-cell tumor of bone is a rare, locally aggressive and rarely metastasizing primary bone tumor. ...Therefore, controversy regarding the treatment of giant-cell tumor of bone is ongoing. Here,
Giant-cell tumor of bone is a rare, locally aggressive and rarely metastasizing primary bone tu
Malignancy in Giant Cell Tumor of Bone: A Review of the Literature.
Palmerini E, Picci P, Reichardt P, Downey G. Palmerini E, et al. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819840000. doi: 10.1177/1533033819840000. Technol Cancer Res Treat. 2019. PMID: 30935298 Free PMC article.
BACKGROUND: Primary and recurrent giant cell tumor of bone is typically benign; however, rarely giant cell tumor of bone can undergo malignant transformation. Malignancy in giant cell tumor
BACKGROUND: Primary and recurrent giant cell tumor of bone is typically benign; however, rarely giant
Updated concepts in treatment of giant cell tumor of bone.
van der Heijden L, Lipplaa A, van Langevelde K, Bovée JVMG, van de Sande MAJ, Gelderblom H. van der Heijden L, et al. Curr Opin Oncol. 2022 Jul 1;34(4):371-378. doi: 10.1097/CCO.0000000000000852. Curr Opin Oncol. 2022. PMID: 35837707 Review.
PURPOSE OF REVIEW: Giant cell tumors of bone (GCTB) are intermediate, locally aggressive primary bone tumors. ...The most frequent mutation (G34W) can be detected using immunohistochemistry and is highly specific in differentiating GCTB from other g
PURPOSE OF REVIEW: Giant cell tumors of bone (GCTB) are intermediate, locally aggressive primary bone tumors. .. …
Multicentric Giant Cell Tumor of Bone.
Errani C, Tsukamoto S, Angulo Alvarado R, Righi A, Nitta Y, Donati DM, Mavrogenis AF. Errani C, et al. Orthopedics. 2023 Nov-Dec;46(6):e376-e380. doi: 10.3928/01477447-20230426-05. Epub 2023 May 2. Orthopedics. 2023. PMID: 37126833
The typical presentation of giant cell tumor of bone is a solitary lesion involving the meta-epiphyseal region of the long bones. ...No lung metastases occurred. Multicentric giant cell tumor of bone tends to e …
The typical presentation of giant cell tumor of bone is a solitary lesion involving the meta-epiphyseal r …
Giant cell tumor of bone.
Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM. Amanatullah DF, et al. Orthopedics. 2014 Feb;37(2):112-20. doi: 10.3928/01477447-20140124-08. Orthopedics. 2014. PMID: 24679193 Review.
EDUCATIONAL OBJECTIVES As a result of reading this article, physicians should be able to: 1. Identify at-risk populations for giant cell tumor of bone. 2. Recognize the biology that drives giant cell tumor of bone
EDUCATIONAL OBJECTIVES As a result of reading this article, physicians should be able to: 1. Identify at-risk populations for giant
Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
Noh BJ, Park YK. Noh BJ, et al. Hum Pathol. 2018 Nov;81:1-8. doi: 10.1016/j.humpath.2018.06.017. Epub 2018 Jun 23. Hum Pathol. 2018. PMID: 29944971 Review.
Giant cell tumor of bone (GCTB)-related clonal aberrations occur in a background of epigenetic histone modifications (especially the G34W mutation of H3F3A gene) that induce cytogenetic abnormalities. ...The "neoplastic" mononuclear stromal cell
Giant cell tumor of bone (GCTB)-related clonal aberrations occur in a background of epigenetic histone mo
Giant cell tumor of bone: current treatment options.
Skubitz KM. Skubitz KM. Curr Treat Options Oncol. 2014 Sep;15(3):507-18. doi: 10.1007/s11864-014-0289-1. Curr Treat Options Oncol. 2014. PMID: 24788576 Review.
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...In most cases the primary driver of the malignant cell appears to be a mutation in H3F3A leading to a substitution of Gly34 to either Trp or L
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...In most c
Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA, Torrence D, Hwang S, Bartelstein M, Healey JH, Hameed M. Yakoub MA, et al. Skeletal Radiol. 2023 Sep;52(9):1791-1798. doi: 10.1007/s00256-023-04292-w. Epub 2023 Feb 14. Skeletal Radiol. 2023. PMID: 36781420 Free PMC article. Review.
Giant cell tumor of bone (GCTB) is a locally aggressive tumor that shows predilection for the metaphysis/epiphysis of long bones, with an incidence of 4-5% of primary bone tumors. GCTB shows two main populations of cells: mononucle
Giant cell tumor of bone (GCTB) is a locally aggressive tumor that shows predilection for the meta
Giant cell tumor of bone in an eighteenth-century Italian mummy.
Ventura L, Petrella E, Piciucchi S, Cilli E, Luiselli D, Feeney RNM, Traversari M. Ventura L, et al. Virchows Arch. 2021 Dec;479(6):1255-1261. doi: 10.1007/s00428-021-03192-5. Epub 2021 Aug 30. Virchows Arch. 2021. PMID: 34462806 Free PMC article.
Giant cell tumor (GCT) of the bone is a locally aggressive and rarely metastasizing neoplasm. ...Giant cells occur in numerous other pathologic conditions of the bone, which accounts for the misrepresentation of these non-GCT tumors in th
Giant cell tumor (GCT) of the bone is a locally aggressive and rarely metastasizing neoplasm. ...Giant ce
5,598 results